US MDMA (Medical Device Manufacturers Association) speech shows user fees as uppermost in Crawford's mind
This article was originally published in Clinica
Executive Summary
FDA acting commissioner Lester Crawford told a device industry group this week that he would be willing to negotiate a change in the user fee programme that would keep user fees fixed, while allowing agency funding to fluctuate, depending upon the number of applications, Karen Riley writes from Washington.